Home - Products - Others - Other Targets - Smurf-1 modulator CMP Example 20

Smurf-1 modulator CMP Example 20

CAS No. 1825371-51-4

Smurf-1 modulator CMP Example 20( —— )

Catalog No. M37331 CAS No. 1825371-51-4

Smurf-1 modulator CMP Example 20 (Smurf-1-IN-20) is a potent Smurf-1 modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 416 In Stock
10MG 598 In Stock
25MG 927 In Stock
50MG 1200 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Smurf-1 modulator CMP Example 20
  • Note
    Research use only, not for human use.
  • Brief Description
    Smurf-1 modulator CMP Example 20 (Smurf-1-IN-20) is a potent Smurf-1 modulator.
  • Description
    Smurf-1 modulator CMP Example 20 (Smurf-1-IN-20) is a potent Smurf-1 modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1825371-51-4
  • Formula Weight
    446.54
  • Molecular Formula
    C23H34N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(N(C)C(C)=C1NC(=O)C=2C(C)=C(ON2)[C@H]3[C@H](C)OC(C)(C)CO3)C4CCCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Carasiphenol C

    Carasiphenol C is a natural product from Carex humilis Leyss.

  • Skimmianin

    Skimmianin is a spasmolytic agent. Skimmianin shows pharmacol. props. similar to 2-(Methylamino)-1-phenyl-1-propanol BCJ45-G.

  • [Ala286]-Calmodulin-...

    [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors.